iphepha

imveliso

COVID-19 Antigen Rapid Test Cassette (Colloidal Gold)

Inkcazelo emfutshane:


Iinkcukacha zeMveliso

Iithegi zeMveliso

[OKUHLOSIWEYO UKUSETYENZISWA]
Ikhasethi yoVavanyo oluKhawulezayo lwe-COVID-19 ye-Antigen (i-Saliva) luvavanyo olusecaleni lokuqukuqela logonyo olujoliswe ekubhaqweni okusemgangathweni kwee-antigens ze-SARS-CoV-2 ze-nucleocapsid kumathe kubantu ekurhanelwa ukuba bane-COVID-19 ngumboneleli wabo wezempilo.
Iziphumo zezokuchongwa kwe-SARS-CoV-2 nucleocapsid antigen.I-Antigen ibonakala ngokubanzi kumathe ngexesha lesigaba esinzima sosulelo.Iziphumo ezilungileyo zibonisa ubukho be-antigens yentsholongwane, kodwa ukulungelelaniswa kweklinikhi kunye nembali yesigulane kunye nolunye ulwazi lokuxilonga luyimfuneko ukumisela imeko yokusuleleka.Iziphumo ezincomekayo azilukhuhli usulelo lwebhaktiriya okanye ukosuleleka kunye nezinye iintsholongwane.I-arhente efunyenweyo ayinakuba ngunobangela oqinisekileyo wesifo.
Iziphumo ezibi azilukhupheli ngaphandle usulelo lwe-SARS-CoV-2 kwaye akufuneki lusetyenziswe njengesona siseko sonyango okanye izigqibo zolawulo lwesigulana, kubandakanya nezigqibo zolawulo losulelo.Iziphumo ezibi kufuneka ziqwalaselwe kumxholo wokuvezwa kwesigulana kutshanje, imbali kunye nobukho beempawu zekliniki kunye neempawu ezihambelana ne-COVID-19, kwaye ziqinisekiswe ngovavanyo lwemolekyuli, ukuba kuyimfuneko kulawulo lwesigulana.
Ikhasethi yoVavanyo oluKhawulezayo lwe-COVID-19 (i-Saliva) yenzelwe ukuba isetyenziswe ziingcali zonyango okanye abasebenzi abaqeqeshiweyo abanobuchule bokwenza uvavanyo lokuqukuqela okusecaleni.Imveliso ingasetyenziswa kuyo nayiphi na indawo yelabhoratri kunye nengeyo elebhu ehlangabezana neemfuno ezichazwe kwiMiyalelo yokuSetyenziswa kunye nommiselo wendawo.
[USHWANKATHELO]
Inoveli coronaviruses (SARS-CoV-2) zezohlobo p.I-COVID-19 sisifo esosulelayo esinamandla sokuphefumla.Ngokuqhelekileyo abantu basengozini.Okwangoku, izigulana ezosulelwe yinoveli coronavirus ngoyena mthombo wosulelo;abantu abosulelekileyo abangenazimpawu nabo banokuba ngumthombo wosulelo.Ngokusekelwe kuphando lwangoku lwe-epidemiological, ixesha lokufukamela yi-1 ukuya kwiintsuku ze-14, ubukhulu becala iintsuku ezi-3 ukuya kwezi-7.Iimpawu eziphambili ziquka umkhuhlane, ukukhathala kunye nokukhwehlela okomileyo.Ukuxinana kweempumlo, iimpumlo, umqala obuhlungu, i-myalgia kunye ne-diarrhea zifumaneka kwiimeko ezimbalwa.
[UMGAQO]
Ikhasethi yoVavanyo oluKhawulezayo lwe-COVID-19 ye-Antigen (i-Saliva) luvavanyo olusecaleni lokugobhoza okusekwe kumgaqo wesangweji ye-antibody ephindwe kabini.I-SARS-CoV-2 ye-nucleocapsid protein monoclonal antibody edityaniswe ne-microparticles enemibala isetyenziswa njengesixhobo kwaye itshizwe kwi-conjugation pad.Ngexesha lovavanyo, i-antigen ye-SARS-CoV-2 kumzekelo inxibelelana ne-SARS-CoV-2 i-antibody edityaniswe ne-microparticles enemibala eyenza i-antigen-antibody ebhalwe ngobunzima.Olu bunzima lufudukela kwi-membrane ngesenzo se-capillary kude kube kumgca wovavanyo, apho luya kuthinjwa yi-SARS-CoV-2 ye-nucleocapsid protein monoclonal antibody.Umgca wovavanyo olunemibala (T) uya kubonakala kwifestile yeziphumo ukuba ii-antigens ze-SARS-CoV-2 zikhona kumzekelo.Ukungabikho komgca we-T kubonisa umphumo ongalunganga.Umgca wolawulo (C) usetyenziselwa ulawulo lwenkqubo, kwaye kufuneka uhlale ubonakala ukuba inkqubo yokuvavanya yenziwa ngokufanelekileyo.
[IZILUMKISO KUNYE NEMIGAQO]
•Ukusetyenziswa kwe-in vitro diagnostic kuphela.
•Kubasebenzi bokhathalelo lwempilo kunye nabantu abaqeqeshiweyo kwindawo yokhathalelo.
•Musa ukusebenzisa le mveliso njengesona siseko sokuxilonga okanye ukungabandakanyi
Usulelo lwe-SARS-CoV-2 okanye ukwazisa ubume bosulelo lwe-COVID-19.
•Musa ukusebenzisa le mveliso emva kokuphelelwa kwexesha.
•Nceda ufunde lonke ulwazi olukweli phetshana phambi kokuba wenze uvavanyo.
•Ikhasethi yovavanyo kufuneka ihlale kwisingxobo esivaliweyo de isetyenziswe.
•Yonke imizekelo kufuneka ithathwe njengeyingozi kwaye iphathwe ngendlela efanayo ne-arhente eyosulelayo.
•Ikhasethi yovavanyo esetyenzisiweyo kufuneka ilahlwe ngokwemithetho yomanyano, karhulumente kunye neyengingqi.
[UHLELO]
Izixhobo ezibonelelweyo
•Iikhasethi zoVavanyo: ikhasethi nganye ene-desiccant kwisingxobo sefoil
•Izixhobo zokukhupha: i-ampoule ene-0.3 mL ye-reagent yokutsalwa
•Abaqokeleli bamathe
• Imibhobho yokuqokelela
•Iidropha
•Ipakeji Faka
Izixhobo ezifunekayo kodwa ezingabonelelwanga
•Isibali-xesha
[UGCINA KUNYE NOZInzo]
•Gcina njengoko zipakishwe kwisingxobo esivaliweyo kwiqondo lobushushu (4-30°C okanye 40-86T).Ikhithi izinzile ngaphakathi komhla wokuphelelwa oshicilelwe kwilebhile.
• Nje ukuba uvule isingxobo, uvavanyo kufuneka lusetyenziswe kwiyure enye.Ukuba sesichengeni ixesha elide kwindawo eshushu nefumileyo kuya kubangela ukuwohloka kwemveliso.
•I-LOT kunye nomhla wokuphelelwa kwawo zashicilelwa kwilebhile.
[UKUQOKELELWA KOMLINGANI NOKULUNGISELELA]
UNGABEki nantoni na emlonyeni kuquka ukutya, isiselo, itshungama okanye iimveliso zecuba ubuncinane imizuzu engama-30 phambi kokuba uyiqokelele.
Sebenzisa ityhubhu yokuqokelela kunye nomqokeleli wamathe ukuqokelela amathe.Faka umqokeleli wamathe kwityhubhu yokuqokelela, emva koko ubeke umqokeleli wamathe kufutshane nemilebe kwaye uvumele amathe aqukuqelele kwityhubhu yokuqokelela.Umthamo wamathe kufuneka ube kuphawu lwesikali (approx.300|jL).Ukuba umthamo wamathe mkhulu kakhulu, sebenzisa i-dropper ukuze ususe amathe angaphezulu kude kube isisombululo sokugqibela kuphawu lwesikali (malunga ne-300pL).[OKUHLOSIWEYO UKUSETYENZISWA]
Ikhasethi yoVavanyo oluKhawulezayo lwe-COVID-19 ye-Antigen (i-Saliva) luvavanyo olusecaleni lokuqukuqela logonyo olujoliswe ekubhaqweni okusemgangathweni kwee-antigens ze-SARS-CoV-2 ze-nucleocapsid kumathe kubantu ekurhanelwa ukuba bane-COVID-19 ngumboneleli wabo wezempilo.
Iziphumo zezokuchongwa kwe-SARS-CoV-2 nucleocapsid antigen.I-Antigen ibonakala ngokubanzi kumathe ngexesha lesigaba esinzima sosulelo.Iziphumo ezilungileyo zibonisa ubukho be-antigens yentsholongwane, kodwa ukulungelelaniswa kweklinikhi kunye nembali yesigulane kunye nolunye ulwazi lokuxilonga luyimfuneko ukumisela imeko yokusuleleka.Iziphumo ezincomekayo azilukhuhli usulelo lwebhaktiriya okanye ukosuleleka kunye nezinye iintsholongwane.I-arhente efunyenweyo ayinakuba ngunobangela oqinisekileyo wesifo.
Iziphumo ezibi azilukhupheli ngaphandle usulelo lwe-SARS-CoV-2 kwaye akufuneki lusetyenziswe njengesona siseko sonyango okanye izigqibo zolawulo lwesigulana, kubandakanya nezigqibo zolawulo losulelo.Iziphumo ezibi kufuneka ziqwalaselwe kumxholo wokuvezwa kwesigulana kutshanje, imbali kunye nobukho beempawu zekliniki kunye neempawu ezihambelana ne-COVID-19, kwaye ziqinisekiswe ngovavanyo lwemolekyuli, ukuba kuyimfuneko kulawulo lwesigulana.
Ikhasethi yoVavanyo oluKhawulezayo lwe-COVID-19 (i-Saliva) yenzelwe ukuba isetyenziswe ziingcali zonyango okanye abasebenzi abaqeqeshiweyo abanobuchule bokwenza uvavanyo lokuqukuqela okusecaleni.Imveliso ingasetyenziswa kuyo nayiphi na indawo yelabhoratri kunye nengeyo elebhu ehlangabezana neemfuno ezichazwe kwiMiyalelo yokuSetyenziswa kunye nommiselo wendawo.
[USHWANKATHELO]
Inoveli coronaviruses (SARS-CoV-2) zezohlobo p.I-COVID-19 sisifo esosulelayo esinamandla sokuphefumla.Ngokuqhelekileyo abantu basengozini.Okwangoku, izigulana ezosulelwe yinoveli coronavirus ngoyena mthombo wosulelo;abantu abosulelekileyo abangenazimpawu nabo banokuba ngumthombo wosulelo.Ngokusekelwe kuphando lwangoku lwe-epidemiological, ixesha lokufukamela yi-1 ukuya kwiintsuku ze-14, ubukhulu becala iintsuku ezi-3 ukuya kwezi-7.Iimpawu eziphambili ziquka umkhuhlane, ukukhathala kunye nokukhwehlela okomileyo.Ukuxinana kweempumlo, iimpumlo, umqala obuhlungu, i-myalgia kunye ne-diarrhea zifumaneka kwiimeko ezimbalwa.
[UMGAQO]
Ikhasethi yoVavanyo oluKhawulezayo lwe-COVID-19 ye-Antigen (i-Saliva) luvavanyo olusecaleni lokugobhoza okusekwe kumgaqo wesangweji ye-antibody ephindwe kabini.I-SARS-CoV-2 ye-nucleocapsid protein monoclonal antibody edityaniswe ne-microparticles enemibala isetyenziswa njengesixhobo kwaye itshizwe kwi-conjugation pad.Ngexesha lovavanyo, i-antigen ye-SARS-CoV-2 kumzekelo inxibelelana ne-SARS-CoV-2 i-antibody edityaniswe ne-microparticles enemibala eyenza i-antigen-antibody ebhalwe ngobunzima.Olu bunzima lufudukela kwi-membrane ngesenzo se-capillary kude kube kumgca wovavanyo, apho luya kuthinjwa yi-SARS-CoV-2 ye-nucleocapsid protein monoclonal antibody.Umgca wovavanyo olunemibala (T) uya kubonakala kwifestile yeziphumo ukuba ii-antigens ze-SARS-CoV-2 zikhona kumzekelo.Ukungabikho komgca we-T kubonisa umphumo ongalunganga.Umgca wolawulo (C) usetyenziselwa ulawulo lwenkqubo, kwaye kufuneka uhlale ubonakala ukuba inkqubo yokuvavanya yenziwa ngokufanelekileyo.
[IZILUMKISO KUNYE NEMIGAQO]
•Ukusetyenziswa kwe-in vitro diagnostic kuphela.
•Kubasebenzi bokhathalelo lwempilo kunye nabantu abaqeqeshiweyo kwindawo yokhathalelo.
•Musa ukusebenzisa le mveliso njengesona siseko sokuxilonga okanye ukungabandakanyi
Usulelo lwe-SARS-CoV-2 okanye ukwazisa ubume bosulelo lwe-COVID-19.
•Musa ukusebenzisa le mveliso emva kokuphelelwa kwexesha.
•Nceda ufunde lonke ulwazi olukweli phetshana phambi kokuba wenze uvavanyo.
•Ikhasethi yovavanyo kufuneka ihlale kwisingxobo esivaliweyo de isetyenziswe.
•Yonke imizekelo kufuneka ithathwe njengeyingozi kwaye iphathwe ngendlela efanayo ne-arhente eyosulelayo.
•Ikhasethi yovavanyo esetyenzisiweyo kufuneka ilahlwe ngokwemithetho yomanyano, karhulumente kunye neyengingqi.
[UHLELO]
Izixhobo ezibonelelweyo
•Iikhasethi zoVavanyo: ikhasethi nganye ene-desiccant kwisingxobo sefoil
•Izixhobo zokukhupha: i-ampoule ene-0.3 mL ye-reagent yokutsalwa
•Abaqokeleli bamathe
• Imibhobho yokuqokelela
•Iidropha
•Ipakeji Faka
Izixhobo ezifunekayo kodwa ezingabonelelwanga
•Isibali-xesha
[UGCINA KUNYE NOZInzo]
•Gcina njengoko zipakishwe kwisingxobo esivaliweyo kwiqondo lobushushu (4-30°C okanye 40-86T).Ikhithi izinzile ngaphakathi komhla wokuphelelwa oshicilelwe kwilebhile.
• Nje ukuba uvule isingxobo, uvavanyo kufuneka lusetyenziswe kwiyure enye.Ukuba sesichengeni ixesha elide kwindawo eshushu nefumileyo kuya kubangela ukuwohloka kwemveliso.
•I-LOT kunye nomhla wokuphelelwa kwawo zashicilelwa kwilebhile.
[UKUQOKELELWA KOMLINGANI NOKULUNGISELELA]
UNGABEki nantoni na emlonyeni kuquka ukutya, isiselo, itshungama okanye iimveliso zecuba ubuncinane imizuzu engama-30 phambi kokuba uyiqokelele.
Sebenzisa ityhubhu yokuqokelela kunye nomqokeleli wamathe ukuqokelela amathe.Faka umqokeleli wamathe kwityhubhu yokuqokelela, emva koko ubeke umqokeleli wamathe kufutshane nemilebe kwaye uvumele amathe aqukuqelele kwityhubhu yokuqokelela.Umthamo wamathe kufuneka ube kuphawu lwesikali (approx.300|jL).Ukuba umthamo wamathe mkhulu kakhulu, sebenzisa i-dropper ukuze ususe amathe angaphezulu kude kube isisombululo sokugqibela kuphawu lwesikali (malunga ne-300pL).

cdsvfd

Umzekelo wezoThutho kunye noGcino

Iisampulu ezisandula ukuqokelelwa kufuneka ziqwalaselwe ngokukhawuleza, kodwa kungadlulanga iyure enye emva kokuqokelelwa komfuziselo.

[INKQUBO YOVAVANYO]

Qaphela: Vumela iikhasethi zovavanyo, iirejenti kunye nemizekelo ukuba zilingane nobushushu begumbi (15-30 °C okanye 59-86T) phambi kovavanyo.

Beka ityhubhu yokuqokelela kunye nomqokeleli wamathe onamathe kwindawo yokusebenza.Khulula isiciko se-reagent yokutsalwa.Yongeza zonke ii-reagents zokukhutshwa kwi-tube yokuqokelela.

cdbgb

Lahla umqokeleli wamathe;Gubungela ityhubhu yokuqokelela ngencam yedropha kwityhubhu yokuqokelela.Gubha ityhubhu yokuqokelela ngaphezu kwamaxesha amathathu ngamandla ukuxuba amathe kunye ne-reagent yokukhupha, uze ucofe isisombululo esixutywe ngamaxesha alishumi ukuvumela ukuba i-saliva ixutywe kakuhle.

cbvgfb

Susa ikhasethi yovavanyo kwisingxobo esivaliweyo.

Buyisa ityhubhu yokuqokelela, ubambe ityhubhu ngokuthe tye, udlulise amathontsi ama-3 (malunga ne-100pL) ngokucothayo kwi-specimen well (S) yekhasethi yovavanyo, emva koko uqalise isibali-xesha.

Linda imigca enemibala ivele.Ukutolika iziphumo zovavanyo ngemizuzu eyi-15.Sukuzifunda iziphumo emva kwemizuzu engama-20.

csvfdb

[UKUTOLIKWA KWEZIPHUMO]
Okuhle | §  

Kuvela imigca emibini.Omnye umgca onombala uvela ku-H c kwindawo yolawulo (C), kunye nomnye umbala ongu-Jt|jne ibonakala kwindawo yovavanyo (T), kungakhathaliseki ukuba ubungakanani bomgca wovavanyo.

Ibi  

Umgca omnye onemibala ubonakala kwindawo yokulawula (C), kwaye akukho mgca uvela kwindawo yokuvavanya (T).

Ayisebenzi    

Umgca wolawulo uyasilela ukubonakala.Ayonelanga,Umthamo womzekelo okanye inkqubo engachanekanga 5 ubuchule zezona zizathu zinokwenzeka zokusilela komgca wolawulo.Phonononga inkqubo kunye noJtphinda uvavanyo usebenzisa ikhasethi entsha yovavanyo.UkubaJ)ingxaki iyaqhubeka, yeka ukusebenzisa iqashiso ngoko nangoko kwaye uqhagamshelane nomsasazi wakho wendawo.

[ULAWULO LWEMEKO]

Ulawulo lwenkqubo lufakiwe kuvavanyo.Umgca wombala ovela kummandla wolawulo (C) uthathwa njengolawulo lwangaphakathi lwenkqubo.Iqinisekisa umthamo owaneleyo we-specimen, i-membrane eyaneleyo ye-wicking kunye nobuchule obuchanekileyo benkqubo.

Imigangatho yolawulo ayibonelelwanga nale khithi.Nangona kunjalo, kucetyiswa ukuba ulawulo oluqinisekileyo kunye nolungalunganga luvavanywe njengoqheliselo olululo lwaselabhoratri ukuqinisekisa inkqubo yovavanyo kunye nokuqinisekisa ukusebenza ngokufanelekileyo kovavanyo.

[IMIDA]

Imveliso ilinganiselwe ukunika ubhaqo olusemgangathweni.Ubunzima bomgca wovavanyo abudibanisi ukudibanisa nokuxininisa kwe-antigen yeesampuli.
Iziphumo ezibi aziluthinteli usulelo lwe-SARS-CoV-2 kwaye akufuneki lusetyenziswe njengesona siseko sezigqibo zolawulo lwesigulana.
Ugqirha kufuneka atolike iziphumo ngokubambisana nembali yesigulane, iziphumo ezibonakalayo kunye nezinye iinkqubo zokuxilonga.
Isiphumo esibi singenzeka ukuba ubuninzi bee-antigens ze-SARS-CoV-2 ezikhoyo kwisampulu zingaphantsi komda wokubonwa we-assay, okanye intsholongwane iye yatshintsha (ii) ezincinci ze-amino acid kwingingqi ye-epitope ekujoliswe kuyo evunyiweyo zii- monoclonal antibodies. isetyenziswe kuvavanyo.

[IIMPAWU ZOKUSEBENZA]

Ukusebenza kweklinikhi

Ukusebenza kwezonyango kwe-COVID-19 Antigen Rapid Test Cassette (Saliva) yasekwa kuphononongo olulindelekileyo kunye nemizekelo eqokelelwe kwizigulane ezineempawu ezingama-628 (kwisithuba seentsuku ezisi-7 iqalile) kunye nezigulana ezingenazimpawu ezikrokrelwayo nge-COVID-19.

Isishwankathelo sedatha ye-COVID-19 yoVavanyo oluKhawulezayo lwe-Antigen njengoko lungezantsi:

I-RT-PCR cycle threshold (Ct) lixabiso lesignali efanelekileyo.Ixabiso elisezantsi le-Ct libonisa umthamo wentsholongwane egazini.Uvakalelo lubalwe kuluhlu lwexabiso le-Ct eyahlukileyo (ixabiso le-CtW37)

I-Antfgeno COVID-19

I-RT-PCR

Iyonke

Positivo

Negativo

HEO®

Positivo

172

0

172

Negativo

3

453 456

Iyonke

175

453 628

IsiVumelwano sePhesenti eNgcono (PPA)=98.28%(172/175),(95%CI:95.08%~99.41%)

IsiVumelwano seepesenti esiNegative(NPA)=100%(453/453),(95%CI:99.15%~100%)

I-PPA-IsiVumelwano sePesenti eNgconoyo (Uvakalelo)

NPA-Negative Percent Agreement (Specific)

Umda wokuFumana (Uvakalelo loHlalutyo)

Uphononongo lusebenzise intsholongwane ye-SARS-CoV-2 ekhulisiwe (Isolate Hong Kong/ VM20001061/2020, NR-52282), engasebenziyo ubushushu kwaye ifakwe ematheni.Umda wokuFumana (LoD) yi-8.6 X102TCIDso/mL.

UkuNqabelelana kweReactivity (Ingcaciso yoHlahlo)

I-Cross reactivity yavavanywa ngokuvavanya i-32 commensal kunye ne-pathogenic microorganisms enokuthi ibe khona kwi-oralcavity.

Akukho-cross-reactivity yabonwa kunye neprotheni ye-MERS-CoV NP xa ivavanywa kwi-concentration ye-50 pg / mL.

Akukho-reactivity ye-cross-reactivity yabonwa kunye neentsholongwane ezilandelayo xa zivavanywa kwi-concentration ye-1.0x106PFU/mL: Umkhuhlane A (H1N1), uMkhuhlane A

(H1N1 pdm09), i-Influenza A(H3N2), i-Influenza B(Yamagata), i-Influenza B(Victoria), i-Adenovirus (uhlobo lwe-1, 2, 3, 5, 7, 55), i-metapneumovirus yabantu, intsholongwane yeParainfluenza (uhlobo lwe-1,2, 3, 4), intsholongwane yokuphefumla syncytial, Enterovirus, Rhinovirus, Human coronavirus 229E, Human coronavirus OC43, Human coronavirus NL63, Human coronavirus HKU1.

Akukho-cross-reactivity yabonwa kunye neebhaktheriya ezilandelayo xa zivavanywa kwi-concentration ye-1.0x10 'CFU / mL: Mycoplasma pneumoniae, Chlamy dia pneumoniae, Legionella pneumophila, Haemophilus influenzae, Streptococcus pyogenes (iqela A), Streptococcus pneumoniae, Candida al. aureus.

Ukuphazamiseka

Ezi zinto zilandelayo zokuphazamiseka ezinokubakho ziye zavavanywa kunye ne-COVID-19 Antigen Rapid Test Cassette (Amathe) kugxininiso oludweliswe ngezantsi kwaye kwafunyaniswa ukuba ayichaphazeli ukusebenza kwe-tegt.

Iziyobisi

Ukugxila Iziyobisi

Ukugxila

Mucin

2%

Igazi elipheleleyo

4%

Benzocaine

5 mg/mL

Menthol 10 mg/mL

Ukutshiza ngeempumlo ezinetyuwa

15%

Phenylephrine

15%

Oxymetazoline

15%

Histamine dihydrochloride

10 mg/mL

Tobramycin

5 pg/mL

Mupirocin 10 mg/mL

I-oseltamivir phosphate

10 mg/mL

IZanamivir 5 mg/mL

Arbidol

5 mg/mL

I-Ribavirin

5 mg/mL

I-Fluticasone propionate

5%

Dexamethasone 5 mg/mL

Triamcinolone

10 mg/mL

   

I-High-dose Hook Effect

I-COVID-19 Antigen Rapid Test Cassette (Saliva) yavavanywa ukuya kuthi ga kwi-1.15x1 o' TCIDso/mL ye-SARS-CoV-2 engasebenziyo kwaye akukho siphumo se-hook sedosi ephezulu sibonwayo.

cdsvcds

Hangzhou Heo Technology Co.,Ltd.

Idilesi: Room201, Building3, No.2073 Jinchang Road,

ISitrato saseLiangzhu, kwiSithili saseYuhang, eHangzhou, eTshayina Ikhowudi yePosi:311113

Umnxeba: 0086-571-87352763 I-imeyile:52558565@qq.com

Idilesi ye-Lotus NL BV:Koningin Julianaplein 10, le Verd,

2595AA, eHague, eNetherlands.I-imeyile:Peter@lotusnl.com

Umnxeba:+31644168999

cds

1.Susa i-swab kwiphakheji.

2.Tilt intloko yesigulane ngasemva malunga ne-70 °.

3.1-2Ngelixa ujikeleza ngobunono iswab, faka i-swab malunga ne-2.5 cm (i-intshi eyi-1) kwi-nostril de ukuchasana kuhlangatyezwe kwii-turbinates.

4.Jikelezisa iswabhu kaninzi eludongeni lwempumlo kwaye uphinde kwenye impumlo usebenzisa iswabhu efanayo.

Umzekelo wezoThutho kunye noGcino

Musa ukubuyisela iswazi kwipakethelo yokuqala yeswab.Iisampulu ezisandula ukuqokelelwa kufuneka ziqwalaselwe ngokukhawuleza, kodwa kungadlulanga iyure enye emva kokuqokelelwa komfuziselo.

INKQUBO YOVAVANYO

Phawula:Vumela iikhasethi zovavanyo, iirejenti kunye nemizekelo ukuba zilingane nobushushu begumbi (15-30℃ okanye 59-86℉) phambi kovavanyo.

1.Beka ityhubhu yokukhupha kwindawo yokusebenzela.

2.Hlubula i-aluminium foil seal ukusuka phezulu kwityhubhu yokukhupha equlethe ityhubhu yokukhupha equlethe isithinteli sokukhupha.

3.Isampling ibhekisa kwicandelo 'Ingqokelela yoMfanekiso'.

4.Faka i-specimen ye-nasal swab kwityhubhu yokukhupha equlethe i-reagent yokukhupha.Roll swab ubuncinane amaxesha ama-5 ngelixa ucinezela intloko ngezantsi kunye necala lombhobho wokukhupha.Shiya i-swab yeempumlo kwityhubhu yokukhupha umzuzu omnye.

5.Susa i-swab yeempumlo ngelixa ucinezela amacala ombhobho ukukhupha ulwelo kwi-swab.Isisombululo esithathiweyo siya kusetyenziswa njengesampulu yovavanyo.6.Guqula ityhubhu yokukhupha ngencam yedropha ngokuqinileyo.

cdsvs

7. Susa ikhasethi yovavanyo kwisingxobo esivaliweyo.

8.Buyisa umva ityhubhu yokutsalwa komzekelo, ubambe ityhubhu ngokuthe nkqo, udlulise amathontsi ama-3 (malunga ne-100 μL) ngokucothayo kumthombo womzekelo (S) wekhasethi yovavanyo, emva koko uqalise isibali-xesha.

9.Lindela imigca enemibala ivele.Ukutolika iziphumo zovavanyo ngemizuzu eyi-15.Sukuzifunda iziphumo emva kwemizuzu engama-20.

asfds

UKUTOLIKWA KWEZIPHUMO

 Okuhle C T C T  Kuvela imigca emibini.Umgca omnye onemibala ubonakala ubukhulu bomgca wokuvavanya.
 Ibi   CT  Umgca omnye onemibala ubonakala kwindawo yokulawula (C), kwaye akukho mgca uvela kwindawo yokuvavanya (T).
  

Ayisebenzi

C T CT

Ulawulo umgca iyasilela to vela. Umthamo wesampulu engonelanga okanye ubuchule benkqubo obungachanekanga zezona zizathu ezinokuthi zibe kho zokungaphumeleli komgca wolawulo.Jonga inkqubo kwaye uluphinde uvavanyo usebenzisa ikhasethi entsha yovavanyo.Ukuba ingxaki iyaqhubeka, yeka ukusebenzisa iqashiso ngoko nangoko kwaye uqhagamshelane nomsasazi wakho wendawo.

ULAWULO LWEMEKO

Ulawulo lwenkqubo lufakiwe kuvavanyo.Umgca wombala ovela kummandla wolawulo (C) uthathwa njengolawulo lwangaphakathi lwenkqubo.Iqinisekisa umthamo owaneleyo we-specimen, i-membrane eyaneleyo ye-wicking kunye nobuchule obuchanekileyo benkqubo.

Imigangatho yolawulo ayibonelelwanga nale khithi.Nangona kunjalo, kucetyiswa ukuba ulawulo oluqinisekileyo kunye nolungalunganga luvavanywe njengenkqubo efanelekileyo yaselabhoratri ukuqinisekisa inkqubo yovavanyo kunye nokuqinisekisa ukusebenza ngokufanelekileyo kovavanyo.

IMIDA

•Imveliso ilinganiselwe ukunika ubhaqo olusemgangathweni.Ubunzima bomgca wovavanyo abudibanisi ukudibanisa nokuxininisa kwe-antigen yeesampuli.

•Iziphumo ezibi aziluthinteli usulelo lwe-SARS-CoV-2 kwaye ukuba iimpawu zikhona kufuneka ufune uvavanyo olongezelelekileyo olukhawulezileyo ngeNdlela ye-PCR.

• Ugqirha kufuneka atolike iziphumo ngokubambisana nembali yesigulane, iziphumo zomzimba, kunye nezinye iinkqubo zokuxilonga.

•Isiphumo esibi esifunyenwe kule Khithi kufuneka siqinisekiswe yi-PCR.Isiphumo esibi singenzeka ukuba ubuninzi bee-antigens ze-SARS-CoV-2 ezikhoyo kwisampulu zingaphantsi komda wokubonwa we-assay, okanye intsholongwane iye yatshintsha (ii) ezincinci ze-amino acid kwingingqi ye-epitope ekujoliswe kuyo evunyiweyo zii- monoclonal antibodies. isetyenziswe kuvavanyo.

•Ubuninzi begazi okanye umfinyila kumfanekiso weswab kunokuphazamisana nokusebenza kwaye kunokuvelisa iziphumo ezingezizo.

IIMPAWU ZOKUSEBENZA

Ukusebenza kweklinikhi

Ulawulo lwenkqubo lufakiwe kuvavanyo.Umgca wombala ovela kummandla wolawulo (C) uthathwa njengolawulo lwangaphakathi lwenkqubo.Iqinisekisa umthamo owaneleyo we-specimen, i-membrane eyaneleyo ye-wicking kunye nobuchule obuchanekileyo benkqubo.

Imigangatho yolawulo ayibonelelwanga nale khithi.Nangona kunjalo, kucetyiswa ukuba ulawulo oluqinisekileyo kunye nolungalunganga luvavanywe njengenkqubo efanelekileyo yaselabhoratri ukuqinisekisa inkqubo yovavanyo kunye nokuqinisekisa ukusebenza ngokufanelekileyo kovavanyo.

I-antigen ye-COVID-19 I-RT-PCR Totale
Okuhle Ibi
 

HEO®

Okuhle 212 0 212
Ibi 3 569 572
Iyonke 215 569 784

PPA =98.60% (212/215), (95%CI: 95.68%~99.71%) NPA =100% (569/569), (95%CI: 99.47%~100%).

I-PPA - IsiVumelwano sePhesenti esiNgxamisekileyo (Uvakalelo) NPA - IsiVumelwano sepesenti esiNegative (Ingcaciso) 95% *Amaxesha okuzithemba

Iintsuku ukusuka uphawu I-RT-PCR I-HEO TECHNOLOGY Isivumelwano(%)
0-3 95 92 96.84%
4-7 120 120 100%
Ixabiso leCT I-RT-PCR I-HEO TECHNOLOGY Isivumelwano(%)
Ct≤30 42 42 100%
Ct≤32 78 78 100%
Ct≤35 86 85 98.84%
<37 9 7 77.78%

Umda wokuFumana (Uvakalelo loHlalutyo)

Uphononongo lusebenzise intsholongwane ye-SARS-CoV-2 ekhulisiweyo, engasebenziyo ubushushu kwaye ifakwe kumzekelo we-swab yeempumlo.Umda wokuFumana (i-LoD) ngu-1.0 × 102 TCID50 / mL.

UkuNqabelelana kweReactivity (Ingcaciso yoHlahlo)

I-Cross reactivity ihlolwe ngokuvavanya i-32 commensal kunye ne-pathogenic microorganisms enokuthi ibe khona kwi-nasal cavity.Akukho-cross-reactivity yabonwa kunye neprotheni ye-MERS-CoV NP xa ivavanywa kwi-concentration ye-50 pg / mL.

Akukho-cross-reactivity yabonwa kunye nezi ntsholongwane zilandelayo xa zivavanywa kwi-concentration ye-1.0 × 106 PFU / mL: I-Influenza A (H1N1), i-Influenza A (H1N1pdm09), i-Influenza A (H7N9), i-Influenza A (H3N2), i-Influenza B ( Yamagata), i-Influenza B (Victoria), i-Adenovirus (uhlobo 1, 2, 3, 5, 7, 55), i-metapneumovirus yabantu,

Parainfluenza virus (uhlobo 1, 2, 3, 4), Respiratory syncytial virus, Enterovirus, Rhinovirus, Human coronavirus 229E, Human coronavirus OC43, Human coronavirus NL63, Human coronavirus HKU1.

Akukho kuphinda-phinda kusebenze kwabonwa kunye nale bhaktheriya ilandelayo xa ivavanywa kuxinaniso lwe-1.0 × 107 CFU/mL: Mycoplasma pneumoniae, Chlamydia pneumoniae, Legionella pneumophila, Haemophilus influenzae, Streptococcus pyogenes (iqela A), Streptococcus pneumoniae, Albicans Staphylococcus aureus.

Ukuphazamiseka

Ezi zinto zilandelayo zophazamiseko ezinokubakho ziye zavavanywa kunye ne-COVID-19 Antigen Rapid Test Cassette (eNasal Swab) kugxininiso oludweliswe ngezantsi kwaye zifunyenwe zingachaphazeli ukusebenza kovavanyo.

 

Iziyobisi Ukugxila Iziyobisi Ukugxila
Mucin 2% Igazi elipheleleyo 4%
Benzocaine 5 mg/mL Menthol 10 mg/mL
Ukutshiza ngeempumlo ezinetyuwa 15% Phenylephrine 15%
Oxymetazoline 15% Mupirocin 10 mg/mL
Tobramycin 5 μg/mL IZanamivir 5 mg/mL
I-oseltamivir phosphate 10 mg/mL I-Ribavirin 5 mg/mL
Arbidol 5 mg/mL Dexamethasone 5 mg/mL
I-Fluticasone propionate 5% Histamine

idihydrochloride

10 mg/mL
Triamcinolone 10 mg/mL

I-High-dose Hook Effect

I-COVID-19 Antigen Rapid Test Cassette (Colloidal Gold) yavavanywa ukuya kuthi ga kwi-1.0×10 5 TCID50 /mL ye-SARS-CoV-2 engasebenziyo kwaye akukho siphumo se-hook sedosi ephezulu sibonwayo.

Umbuzo osoloko ubuzwa

1.Lusebenza njani uvavanyo lwe-SARS-CoV-2 Antigen Rapid?Uvavanyo lolokubona umgangatho wee-antigens ze-SARS-CoV-2 kwiisampulu eziqokelelweyo zeswab.Iziphumo ezilungileyo zibonisa ii-antigens ze-SARS-CoV-2 ezikhoyo kumzekelo.

Kufuneka lusetyenziswe nini uvavanyo?

I-antigen ye-SARS-CoV-2 inokubonwa kwintsholongwane ye-acute yokuphefumla, kuyacetyiswa ukuba uqhube uvavanyo xa iimpawu ezibandakanya ukuqala ngesiquphe kokunye kwezi zilandelayo: ukukhohlela, umkhuhlane, ukuphefumla, ukudinwa, ukuncipha kokutya, i-myalgia.

Ngaba isiphumo asichanekanga?

Iziphumo zichanekile njengoko imiyalelo ihlonitshwa ngononophelo.Nangona kunjalo, isiphumo sisenokungachanekanga ukuba isampulu yesampulu ayiyonelanga okanye i-SARS-CoV-2 Antigen Rapid Test iba manzi ngaphambi kokwenza uvavanyo, okanye ukuba inani le-buffer ye-extraction yehla lingaphantsi kwe-3 okanye ngaphezulu kwe-4. Ngaphandle koko, ngenxa yemigaqo ye-immunological ababandakanyekayo, kukho amathuba eziphumo zobuxoki kwiimeko ezinqabileyo.Ukubonisana nogqirha kuhlala kunconywa kwiimvavanyo ezinjalo ezisekelwe kwimigaqo ye-immunological.

Indlela yokutolika uvavanyo ukuba umbala kunye nokuqina kwemigca kuyahluka?Umbala kunye nobunzulu bemigca akubalulekanga ekutolikweni kwesiphumo.Imigca kufuneka ibe homogeneous kwaye ibonakale ngokucacileyo.Uvavanyo kufuneka luthathwe njengento elungileyo nokuba ubungakanani bombala womgca wovavanyo.5.Yintoni ekufuneka ndiyenze ukuba isiphumo sisithi negative?

Isiphumo esinegative sithetha ukuba awunayo okanye umthamo wentsholongwane egazini usezantsi kakhulu

ukuba abonwe luvavanyo.Nangona kunjalo, kuyenzeka ukuba olu vavanyo lunike iziphumo ezingalunganga ezingachanekanga (ubuxoki obungalunganga) kwabanye abantu abane-COVID-19.Oku kuthetha ukuba usenayo i-COVID-19 nangona uvavanyo luthi awunayo.

Ukuba ufumana iimpawu ezifana nentloko, i-migraines, umkhuhlane, ukulahlekelwa yimvakalelo yokuvumba kunye nencasa, qhagamshelana neziko lezonyango elikufutshane usebenzisa imigaqo yegunya lendawo yakho.Ukongeza, unokuphinda uvavanyo ngekhithi yovavanyo entsha.Kwimeko yokurhanelwa, phinda uvavanyo emva kweentsuku ezi-1-2, njengoko i-coronavirus ayinakubonwa ngokuchanekileyo kuzo zonke izigaba zosulelo.Imithetho yomgama kunye nococeko kufuneka igcinwe.Nokuba kukho iziphumo zovavanyo ezibi, umgama kunye nemithetho yococeko kufuneka ijongwe, ukufuduka/ukuhamba, ukuya kwimisitho njalo njalo kufuneka ulandele izikhokelo/iimfuno ze-COVID zasekuhlaleni.6.Yintoni ekufuneka ndiyenze ukuba iziphumo zi-positive?

Iziphumo ezilungileyo zithetha ubukho be-SARS-CoV-2 antigens.Iziphumo ezilungileyo zithetha ukuba kusenokwenzeka ukuba une-COVID-19.Khawuleza uzibeke wedwa ngokuhambelana nezikhokelo zasekhaya kwaye ngoko nangoko uqhagamshelane nogqirha / ugqirha wakho okanye isebe lezempilo lendawo yakho ngokuhambelana nemiyalelo yabasemagunyeni kwindawo yakho.Iziphumo zovavanyo lwakho ziya kujongwa luvavanyo loqinisekiso lwePCR kwaye uya kucaciswa ngamanyathelo alandelayo.

IBHAYIBHILEYOGRAFIYA

Weiss SR,Leibowitz JZ.I-Coronavirus pathogensis, i-Adv Virus Res 2011; 81:85-164

Cui J, li F, Shi ZL.Imvelaphi kunye nokuvela kwe-pathogenic coronaviruses.Nat Rev Microbiol 2019;17:181-192

USu S, Wong G, Shi W, et al.I-Epidemiology, ukuhlanganiswa kwakhona kofuzo, kunye ne-pathogenesis ye-coronaviruses.TrendsMicrobiol 2016;24:4900502.

ISALATHISI SEIMPAWU

cdfd


  • Ngaphambili:
  • Okulandelayo:

  • Bhala umyalezo wakho apha kwaye uwuthumele kuthi